TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian

NCT00539669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: Docetaxel

Sponsor

Sanofi